Presentation TCT 2016 Surgical Outcomes in Primary MR: Results From Expert Surgeons vs Real Life Surgeons Presenter: Michael J. Mack, Francesco Maisano, Patrick M. McCarthy October 30, 2016
Presentation TCT 2016 Procedural Guidance: Beyond TEE - ICE, Navigator, and More Presenter: Paul A. Grayburn, Patrizio Lancellotti, Brij Maini October 30, 2016
Presentation TCT 2016 Emerging Role of CT for Assessment of Mitral Valve Anatomy and Dysfunction Presenter: Paul A. Grayburn, Patrizio Lancellotti, Hasan Jilaihawi October 30, 2016
Presentation TCT 2016 Strengths and Weaknesses of CMR for Quantification of MR Presenter: Paul A. Grayburn, Patrizio Lancellotti, Stamatios Lerakis October 30, 2016
Presentation TCT 2016 Prognostic and Treatment Decision Implications of Exercise Induced Mitral Regurgitation Presenter: Paul A. Grayburn, Patrizio Lancellotti October 30, 2016
Presentation TCT 2016 Echo Quantification of MR Severity: Classification and Common Pitfalls Presenter: Paul A. Grayburn, Patrizio Lancellotti October 30, 2016
Presentation TCT 2016 Whats New and What's Controversial in the US and EU Guidelines? Presenter: Ted Feldman, Allan Schwartz, Catherine M. Otto October 30, 2016
Presentation TCT 2016 Medical Therapy, Revascularization, and CRT for Functional Mitral Regurgitation: Despite Class I Guidelines, Are the Benefits Substantial? Presenter: Ted Feldman, Allan Schwartz, JoAnn Lindenfeld October 30, 2016
Presentation TCT 2016 Epidemiology and Treatment of Primary and Secondary Mitral Regurgitation: Global Perspectives Presenter: Ted Feldman, Allan Schwartz, Ralph Stephan von Bardeleben October 30, 2016
Presentation TCT 2016 A Bioskills Primer for Mitral Valve Device Inventors and Interventionalists Presenter: Ted Feldman, Allan Schwartz, Mark Reisman October 30, 2016
Presentation TCT 2016 My Rosy Prophecy: What Will the Specialty of Mitral Valve Therapeutics Look Like in 10 Years? Presenter: James S. Gammie, James B. Hermiller Jr., Alec S. Vahanian October 30, 2016
Presentation TCT 2016 Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? Surgical Mitral Valve Repair Or Replacement Via A Minimally Invasive Approach Will Be The Gold Standard! Presenter: James S. Gammie, James B. Hermiller Jr., Steven F. Bolling October 30, 2016
Presentation TCT 2016 Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? No, The Bar Is Too High Transcatheter Mitral Repair Will Always Be Safer And Nearly As Effective! Presenter: James S. Gammie, James B. Hermiller Jr., Ted Feldman October 30, 2016
Presentation TCT 2016 Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? Transcatheter MV Replacement Will Become Standard Of Care For Secondary MR! Presenter: James S. Gammie, James B. Hermiller Jr., Stephan Windecker October 30, 2016
Presentation TCT 2016 First Debate: Should The Low Surgical Risk Patient With Degenerative MR Be Offered Mitraclip? Absolutely Not - In No Universe Would That Be Considered Acceptable Care! Presenter: James S. Gammie, James B. Hermiller Jr., Alfredo Trento October 30, 2016
Presentation TCT 2016 First Debate: Should the Low Surgical Risk Patient With Degenerative MR Be Offered Mitraclip? Absolutely! - As Long as He Receives Truly Informed Consent by A Heart Team! Presenter: James S. Gammie, James B. Hermiller Jr., Brian K. Whisenant October 30, 2016
Presentation TCT 2016 Germany Presents: How Did I Treat This Case Presenter: Dariusz Dudek, Petr Kala, Michael Haude October 30, 2016
Presentation TCT 2016 Czech Republic Responds: How Would I Treat This Case? Presenter: Dariusz Dudek, Petr Kala, Martin Mates October 30, 2016
Presentation TCT 2016 Germany Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure? Presenter: Dariusz Dudek, Petr Kala, Michael Haude October 30, 2016
Presentation TCT 2016 From Surgical to Transcatheter Treatment of Tricuspid Regurgitation Presenter: Russell A. Brandwein October 30, 2016